Vitamin D treatment induces in vitro and ex vivo transcriptomic changes indicating anti‐tumor effects. Issue 1 (17th December 2021)

• Record Type: Journal Article
• Authors: Vaughan‐Shaw, Peter G.; Blackmur, James P.; Grimes, Graeme; Ooi, Li‐Yin; Ochocka‐Fox, Anna M.; Dunbar, Karen; von Kriegsheim, Alex; Rajasekaran, Vidya; Timofeeva, Maria; Walker, Marion; Svinti, Victoria; Din, Farhat V. N.; Farrington, Susan M.; Dunlop, Malcolm G.
• Is Part Of: FASEB journal. Volume 36:Issue 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-12-17
• Subjects: colorectal cancer -- gene expression -- vitamin D; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202101430RR
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Vitamin D deficiency is associated with risk of several common cancers, including colorectal cancer (CRC). Here we have utilized patient derived epithelial organoids (ex vivo) and CRC cell lines (in vitro) to show that calcitriol (1, 25OHD) increased the expression of the CRC tumor suppressor gene, CDH1, at both the transcript and protein level. Whole genome expression analysis demonstrated significant differential expression of a further six genes after 1, 25OHD treatment, including genes with established links to carcinogenesis GADD45, EFTUD1 and KIAA1199 . Furthermore, gene ontologies relevant to carcinogenesis were enriched by 1, 25OHD treatment (e.g., 'regulation of Wnt signaling pathway', 'regulation of cell death' ), with common enriched processes across in vitro and ex vivo cultures including ' negative regulation of cell proliferation', 'regulation of cell migration' and 'regulation of cell differentiation' . Our results identify genes and pathways that are modifiable by calcitriol that have links to CRC tumorigenesis. Hence the findings provide potential mechanism to the epidemiological and clinical trial data indicating a causal association between vitamin D and CRC. We suggest there is strong rationale for further well‐designed trials of vitamin D supplementation as a novel CRC chemopreventive and chemotherapeutic agent.